Zymeworks (ZYME) Revenue (2021 - 2026)

Zymeworks (ZYME) has 6 years of Revenue data on file, last reported at $2.4 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 91.12% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $81.3 million (down 12.98% YoY), and the FY2025 full-year result was $106.0 million, up 38.87% from the prior year.
• Revenue slipped to $2.4 million in Q1 2026, from $2.5 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $325.0 million in Q4 2022 to a low of $1.9 million in Q1 2022.
• A 5-year average of $35.0 million and a median of $16.5 million in 2023 frame the typical range for Revenue.
• Across the five-year window, Revenue surged 3962.5% in 2022 and slumped 94.79% in 2023, its largest moves.
• Tracing ZYME's Revenue over 5 years: stood at $325.0 million in 2022, then tumbled by 94.79% to $16.9 million in 2023, then surged by 83.33% to $31.0 million in 2024, then plunged by 91.9% to $2.5 million in 2025, then decreased by 4.25% to $2.4 million in 2026.
• Business Quant data shows ZYME's Revenue at $2.4 million in Q1 2026, $2.5 million in Q4 2025, and $27.6 million in Q3 2025.